UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
GameStop
GME
$8.63B
| $100M | 0.02% |
3,190,980
+3,007,031
| +1,635% | +$77.1M |
|
927
CALL
Pfizer
PFE
$149B
| $100M | 0.02% |
3,767,820
+210,404
| +6% | +$5.71M |
|
928
Toll Brothers
TOL
$14.1B
| $99.9M | 0.02% |
793,048
+368,382
| +87% | +$54.7M |
|
929
PUT
McDonald's
MCD
$196B
| $99.9M | 0.02% |
344,460
-33,800
| -9% | -$10.1M |
|
930
W.R. Berkley
WRB
$26.8B
| $99.8M | 0.02% |
1,704,964
-683,476
| -29% | -$40.9M |
|
931
Vanguard Communication Services ETF
VOX
$5.73B
| $99.7M | 0.02% |
643,708
-9,419
| -1% | -$1.44M |
|
932
PUT
Blackrock
BLK
$175B
| $99.7M | 0.02% |
97,300
+2,500
| +3% | +$2.54M |
|
933
Equity Lifestyle Properties
ELS
$12.5B
| $99.5M | 0.02% |
1,494,684
+837,832
| +128% | +$58.1M |
|
934
Pool Corp
POOL
$7.31B
| $99.2M | 0.02% |
290,912
+194,161
| +201% | +$70.8M |
|
935
BioMarin Pharmaceuticals
BMRN
$11.9B
| $99.2M | 0.02% |
1,508,633
+646,662
| +75% | +$43.3M |
|
936
Vanguard S&P 500 Value ETF
VOOV
$6.68B
| $98.9M | 0.02% |
536,172
+2,105
| +0.4% | +$404K |
|
937
Nice
NICE
$5.69B
| $98.9M | 0.02% |
582,482
+536,530
| +1,168% | +$95.6M |
|
938
CALL
Tandem Diabetes Care
TNDM
$1.29B
| $98.9M | 0.02% |
2,745,312
| – | – |
|
|
PPL
939
PPL Corp
PPL
$26B
| $98.9M | 0.02% |
3,045,887
+189,785
| +7% | +$6.25M |
|
|
HOLX
940
DELISTED
Hologic
HOLX
| $98.8M | 0.02% |
1,370,502
+439,640
| +47% | +$34.3M |
|
941
Jacobs Solutions
J
$16.9B
| $98.8M | 0.02% |
746,450
+160,759
| +27% | +$22.1M |
|
942
PUT
MetLife
MET
$64.3B
| $98.6M | 0.02% |
1,204,100
+18,500
| +2% | +$1.54M |
|
943
PUT
Snowflake
SNOW
$110B
| $98.4M | 0.02% |
637,400
+67,038
| +12% | +$9.44M |
|
944
Dollar General
DG
$28.1B
| $97.9M | 0.02% |
1,291,742
+652,024
| +102% | +$51.4M |
|
945
CALL
Occidental Petroleum
OXY
$55.7B
| $97.9M | 0.02% |
1,981,076
+236,828
| +14% | +$12M |
|
946
Zoom
ZM
$29.7B
| $97.5M | 0.02% |
1,195,014
+588,246
| +97% | +$46.2M |
|
947
Kohl's
KSS
$2.09B
| $97.4M | 0.02% |
6,938,465
+6,145,231
| +775% | +$106M |
|
948
PUT
PepsiCo
PEP
$189B
| $97.3M | 0.02% |
640,029
-204,600
| -24% | -$33.5M |
|
949
Live Nation Entertainment
LYV
$42.3B
| $97.3M | 0.02% |
751,523
+417,077
| +125% | +$52.5M |
|
950
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.44B
| $96.5M | 0.02% |
1,921,834
+53,257
| +3% | +$2.83M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.